www.breastcancertrials.org A site that helps you find breast cancer clinical trials throughout the United States.
Do you have advanced breast cancer: You may qualify for a clinical trial for a potential new treatment
Entinostat, an oral investigational drug, has been shown to inhibit breast cancer in preclinical studies and has shown encouraging data in a randomized phase II study.
What does the study involve?
If you choose to enroll in this study you will be assigned by chance (randomized) to one of two study groups:
- Group A will receive exemestane + entinostat
- Group B will receive exesmestane + placebo (an inactive pill)
Who can participate?
- Trial is open to pre,peri-, and postmenopausal women and all men with hormone receptor positive and/or progesterone receptor-positive breast cancer that cannot be removed by surgery (locally advanced) or has spread (metastasized) to another part of the body.
- Patients will not be eligible if they are HER2-positive.
Learn more about who qualifies and find trial locations near you:
1800-422-6237 or BreastCancerStudyE2112.com
NCI National Clinical Trials Network